Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionPFG Advisors
Latest Disclosed Ownership14,335 shares
Latest Disclosed Value $ 5,043,862
PFG Advisors reports 7.08% increase in ownership of AMGN / Amgen Inc.

On May 5, 2026 - PFG Advisors filed a 13F-HR form disclosing ownership of 14,335 shares of Amgen Inc. (MX:AMGN) valued at $5,043,862 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 13,387 shares of Amgen Inc.. This represents a change in shares of 7.08% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AMGEN COM 031162100 14,335 948 7.08 5,044 15.11 0.2456
2026-01-27 2025-12-31 13F AMGEN COM 031162100 13,387 -9,676 -41.95 4,382 -32.68 0.2127
2025-11-13 2025-09-30 13F AMGEN COM 031162100 23,063 1,588 7.39 6,508 8.56 0.2666
2025-08-07 2025-06-30 13F AMGEN COM 031162100 21,475 3,918 22.32 5,996 9.62 0.2770
2025-05-06 2025-03-31 13F AMGEN COM 031162100 17,557 4,769 37.29 5,470 64.09 0.3057
2025-02-07 2024-12-31 13F AMGEN COM 031162100 12,788 -112 -0.87 3,333 -19.80 0.2041
2024-10-15 2024-09-30 13F AMGEN COM 031162100 12,900 -1,056 -7.57 4,156 -4.68 0.2621
2024-08-08 2024-06-30 13F AMGEN COM 031162100 13,956 8 0.06 4,360 9.96 0.2947
2024-05-07 2024-03-31 13F AMGEN COM 031162100 13,948 44 0.32 3,966 -0.97 0.2898
2024-01-19 2023-12-31 13F AMGEN COM 031162100 13,904 -71 -0.51 4,005 6.60 0.3234
2023-10-13 2023-09-30 13F AMGEN COM 031162100 13,975 269 1.96 3,756 23.43 0.3373
2023-07-20 2023-06-30 13F AMGEN COM 031162100 13,706 435 3.28 3,043 -5.14 0.2317
2023-04-21 2023-03-31 13F AMGEN COM 031162100 13,271 -149 -1.11 3,208 -8.97 0.2684
2023-01-30 2022-12-31 13F AMGEN COM 031162100 13,420 50 0.37 3,525 16.96 0.3452
2022-10-14 2022-09-30 13F AMGEN COM 031162100 13,370 197 1.50 3,013 -5.99 0.3443
2022-07-13 2022-06-30 13F AMGEN COM 031162100 13,173 -20 -0.15 3,205 0.47 0.3626
2022-04-19 2022-03-31 13F AMGEN COM 031162100 13,193 668 5.33 3,190 13.20 0.3185
2022-01-21 2021-12-31 13F AMGEN COM 031162100 12,525 181 1.47 2,818 7.35 0.2775
2021-11-05 2021-09-30 13F AMGEN COM 031162100 12,344 -482 -3.76 2,625 -16.03 0.2903
2021-07-28 2021-06-30 13F AMGEN COM 031162100 12,826 1,194 10.26 3,126 8.02 0.3575
2021-04-27 2021-03-31 13F AMGEN COM 031162100 11,632 343 3.04 2,894 11.48 0.3709
2021-01-26 2020-12-31 13F AMGEN COM 031162100 11,289 372 3.41 2,596 -7.71 0.4395
2020-10-13 2020-09-30 13F AMGEN COM 031162100 10,917 -190 -1.71 2,813 1.70 0.5402
2020-07-16 2020-06-30 13F AMGEN COM 031162100 11,107 -99 -0.88 2,766 4.34 0.6232
2020-04-29 2020-03-31 13F AMGEN COM 031162100 11,206 957 9.34 2,651 8.60 0.7135
2020-01-14 2019-12-31 13F AMGEN COM 031162100 10,249 -141 -1.36 2,441 19.42 0.5989
2019-10-15 2019-09-30 13F AMGEN COM 031162100 10,390 1,089 11.71 2,044 25.32 0.5640
2019-08-05 2019-06-30 13F AMGEN COM 031162100 9,301 686 7.96 1,631 5.57 0.4429
2019-05-08 2019-03-31 13F AMGEN COM 031162100 8,615 -8 -0.09 1,545 -4.92 0.4706
2019-02-19 2018-12-31 13F/A-1 AMGEN COM 031162100 8,623 8,623 1,625 0.5096
2019-01-18 2018-12-31 13F AMGEN COM 031162100 6,692 6,692 1,341 0.4837
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.